Current and Near-Future Technologies to Quantify Nanoparticle Therapeutic Loading Efficiency and Surface Coating...

Area of Science:

• Nanomedicine
• Biotechnology
• Materials Science

Background:

• Active targeting nanoparticles represent advanced drug and gene delivery systems with potential for enhanced therapeutic efficacy.
• Challenges in production scale-up and batch consistency hinder the clinical translation of these nanomedicines.
• Robust quality control is essential for nanoparticle batch repeatability, drug loading, targeting molecule efficacy, and safety.

Purpose of the Study:

• To evaluate limitations of traditional nanoparticle characterization methods.
• To introduce emerging single-molecule analysis technologies for nanoparticle quality control.
• To guide the advancement of active targeting nanoparticle translation into clinical settings.

Main Methods:

• Review of traditional ensemble-average nanoparticle characterization techniques and their limitations.
• Introduction and evaluation of single-molecule analysis technologies for nanoparticle assessment.
• Focus on quantification of therapeutic payload and targeting moiety coating efficiencies.

Main Results:

• Traditional methods struggle with assessing nanoparticle heterogeneity and batch variations.
• Single-molecule analysis provides detailed insights into individual nanoparticle properties.
• Emerging technologies enable precise quantification of drug/gene loading and surface modification.

Conclusions:

• Accurate characterization of nanoparticle heterogeneity is critical for therapeutic outcomes.
• Single-molecule analysis offers superior resolution for quality control of active targeting nanoparticles.
• Advancing characterization technologies is key to overcoming translation barriers for nanomedicines.